Literature DB >> 1626926

Carbamylated haemoglobin in normal, diabetic and uraemic patients.

J T Kwan1, E C Carr, J L Barron, M R Bending.   

Abstract

Carbamylated haemoglobin arises from the non-enzymic modification of haemoglobin monomers by isocyanate derived from the spontaneous dissociation of urea. We measured carbamylated haemoglobin by high performance liquid chromatography in healthy subjects, non-uraemic hospital patients, diabetics, and different groups of uraemic patients. Carbamylated haemoglobin levels were found to be raised in uraemic subjects, but were independent of age, sex, glycaemic state and haemodialysis procedure. There was no significant difference in carbamylated haemoglobin levels between two groups of patients having different modes of dialysis treatment, probably indicating a similar degree of uraemic exposure in these patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1626926     DOI: 10.1177/000456329202900215

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  5 in total

1.  Physicochemical characterization of carbamylated human serum albumin: an in vitro study.

Authors:  Asim Badar; Zarina Arif; Shireen Naaz Islam; Khursheed Alam
Journal:  RSC Adv       Date:  2019-11-11       Impact factor: 4.036

2.  Carbamylation of serum albumin and erythropoietin resistance in end stage kidney disease.

Authors:  Sahir Kalim; Hector Tamez; Julia Wenger; Elizabeth Ankers; Caitlin A Trottier; Joseph J Deferio; Anders H Berg; S Ananth Karumanchi; Ravi I Thadhani
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-22       Impact factor: 8.237

Review 3.  Carbamylated Proteins in Renal Disease: Aggravating Factors or Just Biomarkers?

Authors:  Laëtitia Gorisse; Stéphane Jaisson; Christine Piétrement; Philippe Gillery
Journal:  Int J Mol Sci       Date:  2022-01-05       Impact factor: 5.923

Review 4.  Protein carbamylation in kidney disease: pathogenesis and clinical implications.

Authors:  Sahir Kalim; S Ananth Karumanchi; Ravi I Thadhani; Anders H Berg
Journal:  Am J Kidney Dis       Date:  2014-07-16       Impact factor: 8.860

5.  Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Mellitus and CKD.

Authors:  Lubaina Presswala; Susana Hong; Yael Harris; Isabela Romao; Meng Zhang; Kenar D Jhaveri; Vipul Sakhiya; Steven Fishbane
Journal:  Kidney Med       Date:  2019-09-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.